EA
ABBV icon

Emerald Acquisition’s AbbVie ABBV Stock Holding History

Emerald Acquisition’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$29.9M Sell
474,839
-268,248
-36% -$17.4M 0.06% 386
2016
Q2 		$46M Buy
+743,087
New +$45.3M 0.08% 294

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Emerald Acquisition's ABBV Position: Q3 2016 in Review

Emerald Acquisition reduced its AbbVie (ABBV) stake by 36% in Q3 2016, selling an estimated $17.4M and leaving 474,839 shares worth $29.9M. The position accounts for 0.06% of the portfolio, ranked #386.

Emerald Acquisition first reported a position in ABBV in Q2 2016 and has held it in 2 quarters since. The position peaked at $46M in Q2 2016. 1,653 funds tracked by Wall St. Rank hold ABBV as of Q3 2016.

  • Emerald Acquisition held 474,839 shares of AbbVie worth $29.9M as of Q3 2016.
  • Emerald Acquisition sold 268,248 AbbVie shares in Q3 2016, an estimated $17.4M.
  • AbbVie made up 0.06% of Emerald Acquisition's portfolio in Q3 2016, its #386 holding.
  • Emerald Acquisition first reported a position in AbbVie in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's AbbVie position peaked at $46M in Q2 2016.
  • 1,653 funds tracked by Wall St. Rank held AbbVie as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.